MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer

Roberto Dinami(National Cancer Institute), Annamaria Biroccio(Unknown)
EMBO Molecular Medicine
November 25, 2022
Cited by 41


Related Papers